Philadelphia Business Journal by John George, Reporter
LANGHORNE — Aprecia Pharmaceuticals has raised $25.7 million in an equity offering, one of the largest amounts raised by a local life sciences company this year.
Etienne Perold, CEO of the privately held Bucks County drug-delivery technology company, declined to provide details about the offering at this time. The stock sale was disclosed last week in a filing with the Securities & Exchange Commission provided by FormDs.com.
The identity of the investor or investors in the 8-year-old company were not disclosed in the SEC filing.
Aprecia specializes in developing and manufacturing precision drug-delivery systems and products.